A Phase II Nonrandomised Open-Label Study of Liposomal Daunorubicin (DaunoXome) in Advanced Soft Tissue Sarcoma

Thirty four patients with advanced soft tissue sarcoma not previously treated with an anthracycline were treated with DaunoXome 100mg/m2 every 3 weeks. Thirty-three patients were evaluable for toxicity. Grade 3-4 neutropenia was seen in 20 patients (60.6%), complicated by febrile neutropenia in 2 (6...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: McTiernan, Anne, Whelan, Jeremy, Leahy, Michael, Woll, Penella J., Judson, Ian
פורמט: Artigo
שפה:Inglês
יצא לאור: Hindawi Publishing Corporation 2006
נושאים:
Clinical Study
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC1510953/
https://ncbi.nlm.nih.gov/pubmed/17040090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/SRCM/2006/41080
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים